Pharma Focus America

LATEST NEWSRead more...

16

Jul 2024

AriBio Co., Ltd. and Fujirebio Diagnostics, Inc. Reach Milestone in Advancing Biomarkers for Alzheimer’s Disease and Neurodegeneration

Fujirebio Holdings Inc and its subsidiary Fujirebio Diagnostics Inc have announced a significant achievement in their strategic partnership with AriBio Co Ltd This collaboration focuses on advancing

16

Jul 2024

Integrated DNA Technologies Enters New Licensing Agreement with SeQure Dx to Propel CRISPR-based Therapeutic Development

Integrated DNA Technologies a global leader in CRISPR genome editing solutions has partnered with SeQure Dx a company specializing in offtarget analysis for gene modification in preclinical and clinical

16

Jul 2024

INCOG BioPharma Intensifies Plans for Expansion

INCOG BioPharma Services a prominent contract development and manufacturing organization specializing in sterile injectable biopharmaceuticals has announced a significant expansion of its manufacturing capabilities The company plans to commence construction

15

Jul 2024

Nona Biosciences and Alaya.bio Collaborate on Advancing CAR-T Cell Therapy

Nona Biosciences and Alayabio have announced a collaborative effort aimed at advancing CART cell therapy development through innovative technologies Nona Biosciences known for its HCAb Harbour Mice platform and sitespecific conjugation technology

15

Jul 2024

AusperBio Secures $37 Million in Series A Funding for Advancing AHB-137 Clinical Development Aimed at HBV Cure

AusperBio Therapeutics Inc and Ausper Biopharma Co Ltd collectively AusperBio a privately held clinicalstage biotechnology company have successfully completed a million Series A financing round

12

Jul 2024

Rentschler Biopharma's New Advanced Production Line in Massachusetts Now Fully Operational

Rentschler Biopharma SE a leading global contract development and manufacturing organization specializing in biopharmaceuticals and advanced therapy

press releasesRead more...

ANI Pharmaceuticals Announces the FDA Approval and Launch of L-Glutamine Oral Powder

ANI Pharmaceuticals Inc today announced that following final approval from the US Food and Drug Administration for its Abbreviated New Drug Application the Company launched LGlutamine Oral Powder ANIs LGlutamine Oral

Artelo Biosciences Receives FDA Clearance of its IND Application for ART26.12, a Selective Fatty Acid Binding Protein 5 Inhibitor

Artelo Biosciences Inc a clinicalstage pharmaceutical company focused on modulating lipidsignaling pathways to develop treatments for people living

Kyverna's KYV-101 Receives U.S. FDA RMAT Designation for KYV-101 in the Treatment of Patients With Refractory Stiff-Person Syndrome

Kyverna Therapeutics Inc a patientcentered clinicalstage biopharmaceutical company focused on developing cell therapies for patients suffering

Can-Fite Applies for FDA Orphan Drug Designation for Namodenoson in the Treatment of Pancreatic Cancer

CanFite BioPharma Ltd a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncological and inflammatory diseases today announced that it has submitted

18 - 20

Jul 2024

Pharma India Expo 2024

Telangana, India

29 - 31

Jul 2024

29 - 31

Jul 2024

30 - 01

Jul 2024

chemical indonesia

jakarta barat, Indonesia

15 - 16

Aug 2024

16 - 17

Aug 2024

iPharma Expo 2024

Boston, USA

Testing The WorldCelebrating 70 Years of Nalgene
Thermo Fisher Scientific - mRNA Services
Future Labs Live USA 2024
World Vaccine Congress Europe 2024
World Orphan Drug Congress 2024
Advanced Therapies USA 2024
World Orphan Drug Congress Europe 2024

TOP ARTICLES

  • 1

    Data Analytics and Forecasting in Pharmaceutical Distribution

    Kate Williamson

    Kate, Editorial Team at Pharma Focus America, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.

  • 2

    Addressing the Opioid Crisis: The Role of Pharmaceutical Companies

    Kate Williamson

    Kate, Editorial Team at Pharma Focus America, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.

  • 3

    The Future of Pharma: Integrating Imaging Informatics for Better Outcomes

    Kate Williamson

    Kate, Editorial Team at Pharma Focus America, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.

  • 4

    Innovative Technologies Driving Vaccine Research and Production: A Revolution in Healthcare

    Kate Williamson

    Kate, Editorial Team at Pharma Focus America, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.

KNOWLEDGE BANK

EDITORIAL SECTION

  • Information Technology

    How AI is Transforming the Pharma Industry

    The global pharmaceutical industry is currently facing many wide ranging challenges including an aging population increased life expectancy a rise in chronic conditions reduced funding for treatments reduced numbers of clinical staff the ever increasing cost of drug development and raw materials and supply chain issues